From the 19th century to today, the idea of harnessing the power of the immune system to treat cancer has progressed from theory and scientific research through clinical trials to now innovative treatment strategies. As far back as 1890, a young bone surgeon and cancer researcher, William B. Coley, noticed that cancer patients often experienced remission following infections. This observation was the initial spark of the idea of cancer immunotherapy. Today, scientists have a myriad of options for treating cancers via immunotherapy, and the research field is more active than ever. This poster depicts the many ways by which historical immuno-oncology and cancer research has led to advances in immunotherapies today and beyond.

Register to download this poster to get an in-depth understanding of:

• The history of immuno-oncology research and the great strides in cancer research that have led to promising treatments of a variety of cancers
• Advances in immune checkpoint inhibition, chimeric antigen receptors (CAR) T cells and other emerging research areas
• Immunotherapy treatment types including adoptive cell therapy (ACT), targeted antibodies, immunomodulators and cancer vaccines